Advances in the medical research and clinical applications on the plasma DNA
- PMID: 26835332
- PMCID: PMC4729110
- DOI: 10.3978/j.issn.2224-4336.2014.03.07
Advances in the medical research and clinical applications on the plasma DNA
Abstract
Plasma DNA has had a strong impact and influence on basic medical research and clinical practice since the discovery of low levels of plasma DNA in healthy individuals under different physiological conditions. Although the source of circulating DNA still requires further investigation, a wide range of research has also proven the value of qualitative and quantitative measurements of plasma DNA in many disease conditions. The use of plasma DNA has a biomarker is advantageous due to accessibility, reliability, reproducibility, sensitivity, specific and relatively low cost. Recently, the detection of circulating (plasma) DNA quantitative changes have been using in the studies on the tumor gene mutations and to monitor disease progressing and to predict the disease prognosis. Such technique also has been using other many different fields, particularly in prenatal diagnosis, for which plasma DNA testing is preferable due to non-invasiveness. This article reviews the research progression and clinical applications of plasma DNA in the last several years.
Keywords: Plasma DNA; haematological malignancies; non-invasive tool at diagnosis.
Conflict of interest statement
Similar articles
-
The potential use of cell-free-circulating-tumor DNA as a biomarker for prostate cancer.Expert Rev Mol Diagn. 2016 Aug;16(8):839-52. doi: 10.1080/14737159.2016.1197121. Epub 2016 Jun 20. Expert Rev Mol Diagn. 2016. PMID: 27254598 Review.
-
Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?Lung Cancer. 2005 Jul;49(1):1-12. doi: 10.1016/j.lungcan.2004.12.008. Lung Cancer. 2005. PMID: 15949585 Review.
-
Circulating cell-free DNA, SLC5A8 and SLC26A4 hypermethylation, BRAF(V600E): A non-invasive tool panel for early detection of thyroid cancer.Biomed Pharmacother. 2013 Oct;67(8):723-30. doi: 10.1016/j.biopha.2013.06.007. Epub 2013 Jul 5. Biomed Pharmacother. 2013. PMID: 23931930
-
[Potential of Cell-free Circulating DNA in Diagnosis of Cancer].Klin Onkol. 2015;28(4):251-9. doi: 10.14735/amko2015251. Klin Onkol. 2015. PMID: 26299738 Review. Czech.
-
Clinical applications of maternal plasma fetal DNA analysis: translating the fruits of 15 years of research.Clin Chem Lab Med. 2013 Jan;51(1):197-204. doi: 10.1515/cclm-2012-0601. Clin Chem Lab Med. 2013. PMID: 23072857 Review.
Cited by
-
Herpesvirus-associated diseases: biomarkers and advancements in clinical research.Virol J. 2025 Jun 2;22(1):177. doi: 10.1186/s12985-025-02795-7. Virol J. 2025. PMID: 40457345 Free PMC article. Review.
References
-
- Leon SA, Shapiro B, Sklaroff DM, et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977;37:646-50. - PubMed
-
- Hohaus S, Giachelia M, Massini G, et al. Cell-free circulating DNA in Hodgkin’s and non-Hodgkin’s lymphomas. Ann Oncol 2009;20:1408-13. - PubMed
-
- Hu Y, Ni H. Advance in human free circulating DNA. Yi Chuan 2008;30:815-20. - PubMed
-
- Ellinger J, Bastian PJ, Haan KI, et al. Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators. Int J Cancer 2008;122:138-43. - PubMed
-
- Silva JM, Dominguez G, Garcia JM, et al. Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations. Cancer Res 1999;59:3251-6. - PubMed
Publication types
LinkOut - more resources
Full Text Sources